Lv4
451 积分 2021-05-10 加入
Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines
1天前
已完结
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
3个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
4个月前
已完结
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
4个月前
已完结
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
4个月前
已完结
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
4个月前
已完结
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients
4个月前
已完结
[Clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
4个月前
已完结
Executive summary for the China Kidney Disease Network (CK-NET) 2017–2018 Annual Data Report
5个月前
已完结
Gliflozins in the Management of Cardiovascular Disease
6个月前
已完结
皖公网安备34019202002308
